PE-backed Nexelis to buy ImmunXperts
Nexelis, a portfolio company of Ampersand Capital Partners, has agreed to acquire ImmunXperts, a Belgian provider of in-vitro immunology services.
Nexelis, a portfolio company of Ampersand Capital Partners, has agreed to acquire ImmunXperts, a Belgian provider of in-vitro immunology services.
Copyright PEI Media
Not for publication, email or dissemination